Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK)

Price 1,411.80p on 28-11-2023 at 18:45:08
Change -2.40p -0.17%
Buy 1,410.40p
Sell 1,410.00p
Buy / Sell GSK Shares
Last Trade: Unknown 1,377.00 at 1,412.08p
Day's Volume: 5,168,369
Last Close: 1,411.80p
Open: 1,408.20p
ISIN: GB00BN7SWP63
Day's Range 1,395.00p - 1,411.80p
52wk Range: 1,302.60p - 1,609.00p
Market Capitalisation: £57,814m
VWAP: 1,409.10162p
Shares in Issue: 4,095m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1,377 1,412.08p Ordinary
Currency Conversion
OTC Trade
18:45:06 - 28-Nov-23
Unknown* 1,056 1,400.79734p Ordinary
Currency Conversion
OTC Trade
17:57:42 - 28-Nov-23
Unknown* 1,154 1,408.79p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 1,542 1,404.671p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 1,211 1,406.491p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 1,649 1,404.177p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 1,325 1,407.003p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 8,483 1,405.405p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 159,784 1,407.415p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23
Unknown* 1,929 1,408.206p Ordinary
Currency Conversion
OTC Trade
17:54:18 - 28-Nov-23

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close Volume

Share News for Glaxosmithkline

GSK announces positive results from Blenrep phase 3 blood cancer trial

27th Nov 2023 09:00

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results. Read More

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

22nd Nov 2023 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

21st Nov 2023 11:52

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024. Read More

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

14th Nov 2023 17:04

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook. Read More

GSK hails momelotinib opinion from European Medicines Agency committee

13th Nov 2023 09:47

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia. Read More

FTSE 100 Latest
Value7,455.24
Change-5.46

Login to your account

Forgot Password?

Not Registered